Policy & Medicine September 5, 2024
Thomas Sullivan

In the ever-evolving world of oncology, access to effective treatments and their affordability is a constant concern. In Episode 5 of Oncology Update with Dr. John Marshall, we delve into a topic that affects both cancer patients and healthcare providers: pharmacy benefit managers (PBMs). These middlemen control much of the flow of drugs between manufacturers and patients, but as Dr. Marshall and his guests explain, their role is fraught with complexities that are increasingly impacting the delivery of care in oncology.

PBMs: The Unseen Influencers

Pharmacy Benefit Managers (PBMs) are third-party administrators hired by health plans to manage prescription drug programs. While PBMs were originally introduced to streamline drug access and control costs, they have evolved into powerful entities, with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards
The Evolving Role of Pharmacists in Custom Pathway Implementation
Pharma Pulse 11/25/24: Deepening Patient Relationships,

Share This Article